<?xml version="1.0" encoding="UTF-8"?>
<ref id="B171-vaccines-08-00224">
 <label>171.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McDermott</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Mitchell</surname>
    <given-names>H.D.</given-names>
   </name>
   <name>
    <surname>Gralinski</surname>
    <given-names>L.E.</given-names>
   </name>
   <name>
    <surname>Eisfeld</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Josset</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Bankhead</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Neumann</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Tilton</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Schafer</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus</article-title>
  <source>BMC Syst. Biol.</source>
  <year>2016</year>
  <volume>10</volume>
  <elocation-id>93</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12918-016-0336-6</pub-id>
  <pub-id pub-id-type="pmid">27663205</pub-id>
 </element-citation>
</ref>
